Bio-Pharmaceuticals Formulation

  • Product Selection / Portfolio Prioritization
  • In-licensing and Out-licensing of marketed generics, nutraceuticals, OTC and innovative drug molecules in development
  • Identifying Merger & Acquisition Opportunity
  • Identifying Joint Venture Opportunities
  • Fund raising and valuation for Business Expansion
  • Strategic advisory services on Product & Portfolio Divestment
  • Market Research - Product Market Value assessment
  • Assessment of Para IV Opportunities
  • Biosimilar Landscape and Opportunity Evaluation
  • Competitive landscape analysis on targeted therapy areas to guide innovation/ new product selection
  • Customised Market Entry Strategy for India and Japanese market.
  • Generic pharma company/marketing companies to evolve into Innovators
  • Innovators to foray in the Generic market

MP Advisors exclusive focus and in-depth understanding of pharma Industry over two decades enables the team to offer advisory services to the pharmaceutical companies engaged in Innovation, manufacturing, formulation of drugs, CROs. Our services also extends to Corporate Investors like Private equities, Venture Capital and Angel Investors. Our proprietary database and acquired domain skills support us in advising Private equity/investors in understanding the risk reward of investing in the pharma sector across the globe-US, Europe, Japan and India.

We integrate the team's knowledge and experience to understand the complex science, dynamic market environment shaped by the regulatory approval process to offer end-to- end solution to our clients which aids them in making timely strategic decisions.

We continuously strive to improve our skill sets and understanding to facilitate our customers to view us as long term strategic partners in their business development.



Our Services

Bio-Pharmaceuticals Formulation
Bio-Pharmaceuticals API
CROs & CMOs
Private Equity, VC & Angel Investors